Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

86. Fox A N, Villanueva R, Miller J L. Management of amiodarone extravasation with intradermal hyaluronidase. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2017; 74 : 1545-1548

87. Johnson P N, Skrepnek G H, Golding C L, Owora A H, Thomas A N, Miller J L. Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2017; 74 : 1174-1183

88. Jones A N, Miller J L, Neely S, Ibach B W, Hagemann T M, Golding C L, Lewis T V, Peek L A, Johnson P N. Prevalence of Unrounded Medication Doses and Associated Factors Among Hospitalized Pediatric Patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2017; 22 : 286-292

89. Dannelley J F, Martin E M, Chaaban H, Miller J L. Review of Metronidazole Dosing in Preterm Neonates. American journal of perinatology. 2017; 34 : 833-838

90. Tieu J D, Hopps S, Miller J L, Kupiec K E, Skrepnek G H, Liu C, Smith W J. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2017

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

6. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.


7. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


9. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.


10. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More